RUDN University scientists in pharmaceutical technology proved effectiveness of new dosage form
Researchers developed a new dosage form, amorphous solid dispersion (ASD), to increase drug bioavailability. The study showed that ASD increased efavirenz absorption by up to 16.7 times, making it a promising solution for improving medication efficacy.